ClinicalTrials.gov
ClinicalTrials.gov Menu

Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00091611
Recruitment Status : Terminated (This study was terminated due to low accrual.)
First Posted : September 13, 2004
Last Update Posted : October 26, 2012
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )